Ligand validation:7BPO

HBX: benzaldehyde

HBX is a Ligand Of Interest in 7BPO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7BPO_HBX_A_201	3%	93%	0.336	0.669	0.08	0.4	-	-	0	0	100%	1
7BPO_HBX_B_201	2%	93%	0.328	0.635	0.1	0.37	-	-	0	0	100%	1
7BR1_HBX_A_201	87%	93%	0.085	0.957	0.04	0.42	-	-	0	0	100%	1
3GDN_HBX_B_533	88%	40%	0.077	0.954	1.7	0.71	-	-	0	0	100%	1
4US8_HBX_A_924	67%	78%	0.162	0.971	0.3	0.57	-	-	4	0	100%	0.3
4PLU_HBX_C_201	63%	15%	0.12	0.915	1.49	2.48	2	3	1	0	100%	1
6COI_HBX_A_303	61%	55%	0.143	0.931	0.72	1.01	-	-	4	0	100%	1
3L4L_HBX_A_200	59%	63%	0.13	0.914	0.29	1.1	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.